Therapeutic Inhibition of Neutrophil Activity as a Disease-Modifying Treatment for Amyotrophic Lateral Sclerosis (2022–2025)

Grant type:
United States Congressionally Directed Medical Research Programs - Amyotrophic Lateral Sclerosis Research Program
Researchers:
  • Senior Research Fellow
    School of Biomedical Sciences
    Faculty of Medicine
  • NHMRC Professorial Fellow
    School of Biomedical Sciences
    Faculty of Medicine
Funded by:
United States Department of Defense